Musculo-Skeletal System Medicine use in Belgium exhibited a stable trend from 2024 to 2028, with the rate of Defined Daily Dosage per Thousand Persons per Day remaining relatively constant. The use is forecasted to slightly increase from 56.7 in 2024 to 56.9 by 2028. Year-on-year variations show minimal changes, with almost no growth between consecutive years, highlighting a plateau in consumption. The compound annual growth rate (CAGR) over this period is negligible, indicating a stable market.
Future trends to watch for include the impact of an aging population on musculo-skeletal drug needs, potential breakthroughs in alternative treatments such as biotechnology, and changes in regulatory policies that could affect prescription rates. Additionally, monitoring the development of personalized medicine could be significant for this market.
